dostarlimab-gxly
Showing 1 - 25 of 41
Tumors, Rectal Trial (Dostarlimab)
Not yet recruiting
- Neoplasms, Rectal
- Dostarlimab
- (no location specified)
Feb 2, 2023
Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)
Not yet recruiting
- Recurrent Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 12, 2023
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)
Not yet recruiting
- Recurrent Cancer
- +2 more
-
Lyon, FranceCentre Léon Bérard
May 12, 2023
Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)
Not yet recruiting
- Ovarian Clear Cell Carcinoma
-
Houston, TexasM D Anderson Cancer Center
Sep 26, 2023
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023
Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)
Not yet recruiting
- Adenocarcinoma - GEJ
- Gastric Adenocarcinoma
- (no location specified)
Sep 26, 2023
Tumors Trial in Worldwide (Dostarlimab)
Recruiting
- Neoplasms
- Dostarlimab
-
Birmingham, Alabama
- +105 more
Nov 17, 2022
Brain Metastases Trial in Houston (Niraparib, Dostarlimab)
Not yet recruiting
- Brain Metastases
-
Houston, TexasM D Anderson Cancer Center
Jan 17, 2023
Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)
Not yet recruiting
- Refractory HIV Associated Kaposi Sarcoma
- Dostarlimab in Combination Antiretroviral Therapy
- (no location specified)
Dec 2, 2022
Gestational Trophoblastic Neoplasia Trial in Miami (Dostarlimab)
Not yet recruiting
- Gestational Trophoblastic Neoplasia
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Nov 4, 2022
Tumors, Head and Neck Trial in Worldwide (Dostarlimab, Belrestotug, GSK6097608)
Not yet recruiting
- Neoplasms, Head and Neck
- Dostarlimab
- +2 more
-
New Haven, Connecticut
- +121 more
Oct 3, 2023
Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)
Active, not recruiting
- Head and Neck Cancer
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jan 31, 2023
Head and Neck Squamous Cell Carcinoma Trial in Spain (Dostarlimab, Niraparib, cisplatin plus radiotherapy)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Dostarlimab
- +2 more
-
Badalona, Cataluña, Spain
- +4 more
Mar 13, 2023
Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)
Recruiting
- Stage I Breast Cancer
- +7 more
-
Baltimore, Maryland
- +6 more
Nov 11, 2022
Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Niraparib
- +2 more
-
Washington, District of Columbia
- +2 more
Apr 13, 2022
Endometrial Cancer Trial in France (Carboplatin-Paclitaxel, Dostarlimab)
Recruiting
- Endometrial Cancer
-
Angers, France
- +40 more
Aug 9, 2022
Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)
Recruiting
- Endometrial Cancer
- Intensity modulated radiation therapy (IMRT)
- Dostarlimab
-
Basking Ridge, New Jersey
- +6 more
Jul 5, 2022
Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)
Not yet recruiting
- Gynecologic Cancer
- +3 more
- Cabo + Dostarlimab
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023
Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)
Recruiting
- Rectal Neoplasms
- Rectal Neoplasm Malignant
- Niraparib
- +2 more
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022
Colon Cancer, DMMR Colorectal Cancer Trial (Dostarlimab)
Not yet recruiting
- Colon Cancer
- DMMR Colorectal Cancer
- (no location specified)
Feb 4, 2022
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)
Not yet recruiting
- Recurrent Ovarian Cancer
- +2 more
- (no location specified)
Jul 26, 2022
Lung Cancer, Non-Small Cell Trial in Worldwide (Cobolimab, Dostarlimab, Docetaxel)
Recruiting
- Lung Cancer, Non-Small Cell
- Cobolimab
- +2 more
-
Fountain Valley, California
- +106 more
Apr 12, 2022